DA Davidson Lowers Earnings Estimates for Procter & Gamble

The Procter & Gamble Company (NYSE:PG) – Equities research analysts at DA Davidson decreased their Q2 2025 earnings per share (EPS) estimates for Procter & Gamble in a note issued to investors on Tuesday, November 26th. DA Davidson analyst L. Weiser now anticipates that the company will post earnings of $1.87 per share for the quarter, down from their previous forecast of $1.93. DA Davidson currently has a “Buy” rating and a $209.00 price target on the stock. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.96 per share. DA Davidson also issued estimates for Procter & Gamble’s FY2025 earnings at $7.03 EPS and FY2026 earnings at $7.49 EPS.

PG has been the topic of several other reports. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Piper Sandler started coverage on Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a research note on Monday, September 30th. Finally, JPMorgan Chase & Co. upped their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $180.45.

Procter & Gamble Trading Up 1.1 %

Shares of NYSE PG opened at $179.31 on Wednesday. The business’s 50 day moving average is $170.11 and its two-hundred day moving average is $168.83. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. Procter & Gamble has a 1-year low of $142.50 and a 1-year high of $179.46. The stock has a market capitalization of $422.28 billion, a P/E ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the firm posted $1.83 earnings per share. The firm’s revenue for the quarter was down .6% on a year-over-year basis.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.25%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Insider Activity

In related news, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This represents a 2.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the completion of the transaction, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 35,233 shares of company stock worth $6,024,234. Insiders own 0.18% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Concurrent Investment Advisors LLC grew its position in Procter & Gamble by 4.5% during the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after purchasing an additional 4,035 shares during the period. Radnor Capital Management LLC acquired a new stake in shares of Procter & Gamble during the 3rd quarter valued at about $5,705,000. Welch Group LLC grew its position in shares of Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares during the period. Swiss National Bank grew its position in shares of Procter & Gamble by 0.6% during the 3rd quarter. Swiss National Bank now owns 7,005,790 shares of the company’s stock valued at $1,213,403,000 after acquiring an additional 39,000 shares during the period. Finally, GAMMA Investing LLC grew its position in shares of Procter & Gamble by 67.2% during the 2nd quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after acquiring an additional 10,777 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.